一、重要奖项

1. 耐药结核病精准诊疗关键技术研究及推广应用  北京市科技进步二等奖  202209

2. DOTS-PLUS策略下耐药肺结核医防合作与新型诊断技术应用 陕西省科学技术奖三等奖 201912

3. 中华医学会结核病学分会2017年度杰出青年人才奖中华医学会结核病学分会2017年度杰出青年人才奖 无 201705

4. 吉林省结核病耐药监测技术平台的建立和耐药谱研究 吉林省科学技术奖 三等奖 201611

5. 我国耐药结核病流行状况及关键防治技术的研究 中华预防医学会科学技术奖三等奖 201601

6. 我国耐药结核病流行状况及关键防治技术的研究 中华医学会科技奖 二等奖 201412

7. 棉花纤维细胞伸长发育的基础研究 中华人民共和国教育部自然科学 一等奖 200901

二、重要学术论文

1. Yuhong Liu#,Jingtao Gao,Jian Du,WeiShu,Lu Wang,Yufeng Wang,Zhongtan Xue,Liang Li*,Shaofa Xu*,Yu Pang*.Acquisitionof clofazimine resistance following bedaquiline treatment formultidrug-resistant tuberculosis. Int J Infect Dis. 2020,102:392-396.SCI

2. Fengmin Huo#,Yifeng Ma#,RongmeiLiu#,Liping Ma#,Shanshan Li,Guanglu Jiang,Fen Wang,Yuanyuan Shang,LinglingDong,Yu Pang*.Interpretation of Discordant Rifampicin Susceptibility TestResults Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing.Open Forum Infect Dis. 2020,7(8):ofaa279.SCI

3. Fengmin Huo#,Yifeng Ma#,Shanshan Li#,YiXue,Yuanyuan Shang,Lingling Dong,Yunxu Li,Yu Pang*.Specific gyrA Gene MutationsCorrelate with High Prevalence of Discordant Levofloxacin Resistance inMycobacterium tuberculosis Isolates from Beijing, China. J Mol Diagn.2020,22(9):1199-1204.SCI

4. Jun Fan#,Jun An#,Wei Shu#,FengminHuo,Shanshan Li,Fen Wang,Shibing Qin*,Yu Pang*.Epidemiology of skeletaltuberculosis in Beijing, China: a 10-year retrospective analysis of data. Eur JClin Microbiol Infect Dis. 2020,39(11):2019-2025.SCI

5. Qian Liang#,Yuanyuan Shang#,FengminHuo,Yi Xue,Yunxu Li,Lingling Dong,Shanshan Li*,Yu Pang*.Assessment of currentdiagnostic algorithm for detection of mixed infection with Mycobacteriumtuberculosis and nontuberculous mycobacteria. J Infect Public Health.2020,13(12):1967-1971.SCI

6. Jun Wang#,Weijie Zhao#,RongmeiLiu#,Fengmin Huo,Lingling Dong,Yi Xue,Yufeng Wang,Zhongtan Xue,Liping Ma*,YuPang*.Rapid Detection of Ethambutol-Resistant Mycobacterium tuberculosis fromSputum by High-Resolution Melting Analysis in Beijing, China. Infect DrugResist. 2020, 20;13:3707-3713.SCI

7. Jingtao Gao#,Yi Pei#,XiaofengYan#,Guomin Shi#,Tongxin Li#,Mengqiu Gao#,Yuhong Liu,Yufeng Wang,Wei Shu,LiangLi*,Yu Pang*.Emergence of nontuberculous mycobacteria infections duringbedaquiline-containing regimens in multidrug-resistant tuberculosis patients.Int J Infect Dis. 2020,100:196-198.SCI

8. Zhen Zhou#,Yujie Dong#,ChenghaiLi,Dongpo Wang,Yan Lv,Pingxin Lv*,Yu Pang*.Determining the optimal puncturesite of CT-guided transthoracic needle aspiration biopsy for the diagnosis oftuberculosis. J Thorac Dis. 2020,12(8):3987-3994..SCI

9. Yuhong Liu#,Mengqiu Gao#,Jian Du#,LuWang#,Jingtao Gao#,Wei Shu,Yufeng Wang,Zhongtan Xue,Liang Li*,Yu Pang*.Reducedsusceptibility of Mycobacterium tuberculosis to bedaquiline duringantituberculosis treatment and its correlation with clinical outcomes in China.Clin Infect Dis. 2020, 15:ciaa1002.SCI

10. Zhuo-Hong Yan#,Bing Zhao,YuPang,Xiao-Jue Wang ,Ling Yi,He-Lin Wang,Bin Yang ,Pan-Jian Wei,Hong-YanJia,Shu-Ping Li,Yan-Lin Zhao*,Hong-Tao Zhang*,.Generation of mycobacteriallipoarabinomannan-specific monoclonal antibodies and their ability to identifymycobacterium isolates.. J Microbiol Immunol Infect..2020,S1684-1182(20):30033-5.SCI

11. Hou J #, Pang Y# , Yang X , Chen T ,Yang H , Yang R , Chen L , Xu L *.Outbreak of Mycobacterium tuberculosisBeijing Strain in a High School in Yunnan, China.. Am J Trop Med Hyg.. 2020,Feb24:19-0533.SCI

12. Jianjie Wang#, Meilan Zhou, Zi Chen,Cong Chen, Gang Wu, Yingping Zuo, Xin Ren, Zhuan Chen, Weihua Wang*， Yu Pang*.Survival of patients with multidrug-resistant tuberculosisin Central China: a retrospective cohort study. Epidemiol Infect.. 2020,Feb19:148:e50.SCI

13. Huo F #, Zhang F #, Xue Y , Shang Y ,Liang Q , Ma Y , Li Y , Zhao L , Pang Y *.Increased prevalence oflevofloxacin-resistant Mycobacterium tuberculosis in China is associated withspecific mutations within the gyrA gene. Int J Infect Dis.. 2020,Mar（92）:241-246.SCI

14. Ma Y #, Fan J #, Li S #, Dong L , Li Y, Wang F , Huo F , Pang Y * Qin S *.Comparison of Lowenstein-Jensen medium andMGIT culture system for recovery of Mycobacterium tuberculosis from abscesssamples.. Diagn Microbiol Infect Dis.. 2020,96(4):114969.SCI

15. Du J #， Shu W #， Liu Y #， Wang Y , Zhan Y , Yu K , Gao J ,Li L* , Pang Y *.Multicenter feasibility study to assess external qualitypanels for molecular diagnostics for tuberculosis in China.. Eur J ClinMicrobiol Infect Dis.. 2020,39(2):339-343.SCI

16. Shu W #, Du J #, Liu Y#, Wang Y , HuoF, Jiang G , Li L* , Pang Y *.External quality control of phenotypic drugsusceptibility testing for Mycobacterium tuberculosis in China.. Eur J ClinMicrobiol Infect Dis.. 2020, Jan 2:【未填写起止页码】.SCI

17. Dong W # , Li S # , Wen S # , Jing W ,Shi J , Ma Y , Huo F , Gao F *, Pang Y*, Lu J *.In Vitro Susceptibility Testingof GSK656 against Mycobacterium Species. Antimicrob Agents Chemother..2020,64(2):pii: e01577-19.SCI

18. Liu R #, Li J #, Tan Y #, Shang Y , LiY , Su B ， Shu W , Pang Y *, Gao M *, Ma L*.Multicenterevaluation of the acid-fast bacillus smear, mycobacterial culture, XpertMTB/RIF assay, and adenosine deaminase for the diagnosis of tuberculousperitonitis in China.. Int J Infect Dis.. 2020,Jan;90:119-124.SCI

19. Yifeng Ma # , Jun Fan # , Shanshan Li #, Lingling Dong , Yunxu Li , Fen Wang , Fengmin Huo , Yu Pang* , ShibingQin*.Comparison of Lowenstein-Jensen medium and MGIT culture system forrecovery of Mycobacterium tuberculosis from abscess samples. Diagn. Microbiol.Infect. Dis. . 2020,96(4):114969.SCI

20. Zhang F # , Li S# , Wen S, Zhang T,Shang Y , Huo F , Xue Y , Li L* , Pang Y *.Comparison of in vitroSusceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn,the Deazoflavin-Dependent Nitroreductase from Mycobacterium tuberculosis..Infect Drug Resist.. 2020,Mar 11;13:815-822.SCI

21. Lin S #, Wei S , Zhao Y , Lin J *， Pang Y*.Epidemiology Of Human Pulmonary Infection WithNontuberculous Mycobacteria In Southeast China: A Prospective SurveillanceStudy.. Infect Drug Resist.. 2019,Nov 12;12:3515-3521.SCI

22. Zhengwei Liua#, Huali Dong # , BeiBeiWua , Mingwu Zhanga , Yelei Zhua , Yu Pang∗ , Xiaomeng Wang*.Isrifampin resistance a reliable predictive marker of multidrug-resistant tuberculosisin China: A meta-analysis of findings. J. Infect. . 2019,79(4):349-356.SCI

23. Fengmin Huo# , Jie Lu# , Zhaojing Zong,Wei Jing, Jin Shi , Yifeng Ma , Lingling Dong , Liping Zhao , Yufeng Wang ,Hairong Huang ,Yu Pang*.Change in prevalence and molecular characteristics ofisoniazid-resistant tuberculosis over a 10-year period in China. BMC Infect.Dis. . 2019,19(1):689.SCI

24. Jian Du#, Wei Shu, Yuhong Liu, YufengWang, Ying Zhan, Kexin Yu,Jingtao Gao, Liang Li*,Yu Pang*.Development andvalidation of external quality assessment panels for mycobacterial culturetesting to diagnose tuberculosis in China. Eur. J. Clin. Microbiol. Infect.Dis.. 2019,38(10):1961-1968.SCI

25. Tingting Zhang,* Guanglu Jiang,* Shu’anWen,* Fengmin Huo, Fen Wang, Hairong Huang*,Yu Pang*.Para-aminosalicylic acidincreases the susceptibility to isoniazid in clinical isolates of Mycobacteriumtuberculosis. Infect Drug Resist. 2019,12:825-829.SCI

26. Mingguan Lin# , Yeteng Zhong , ZhuolinChen, Chong Lin , Hua Pei , Wei Shu, Yu Pang*.High incidence of drug-resistantMycobacterium tuberculosis in Hainan Island, China. Trop. Med. Int. Health .2019,24(9):1098-1103.SCI

27. Qingtao Liang#, Yu Pang# , Yang Yang ,Hua Li , Chao Guo , Xinting Yang, Xiaoyou Chen*.An improved algorithm for rapiddiagnosis of pleural tuberculosis from pleural effusion by combined testingwith GeneXpert MTB/ RIF and an anti-LAM antibody-based assay. BMC Infect. Dis.. 2019,19(1):548.SCI

28. Hui Liu#, Fang Dong,Jinrong Liu,Jianhua Liu, Yu Pang, Shunying Zhao,Jie Lu*, Huimin Li*.Successful managementof Mycobacterium abscessus complex lung disease in an otherwise healthy infant.Infect Drug Resist . 2019,12:1277-1283.SCI

29. Jing Wang#, Yu Pang#, Wei Jing#, WeiChen#,Ru Guo#,Xiqin Han, Limin Wu, Guangxu Yang, Kunyun Yang,Cong Chen, LinJiang,Chunkui Cai, Zhi Dou, Lijuan Diao,Hongqiu Pan, Jianyun Wang, Feifei Du,Tao Xu, Lixia Wang, Renzhong Li*,Naihui Chu*.Efficacy and safety ofcycloserine-containing regimens in the treatment of multidrug-resistanttuberculosis: a nationwide retrospective cohort study in China. Infect DrugResist . 2019,12:763-770.SCI

30. Qiyao Chai#, Xudong Wang, Lihua Qiang,Yong Zhang, Pupu Ge, Zhe Lu, Yanzhao Zhong, Bingxi Li , Jing Wang , LingqiangZhang, Dawang Zhou , Wei Li, Wenzhu Dong, Yu Pang, George Fu Gao , Cui Hua Liu*.A Mycobacterium tuberculosis surface protein recruits ubiquitin to triggerhost xenophagy. Nat Commun. 2019,10(1):1973.SCI

31. Yu Pang # , Wei Jing # , Jie Lu# ,Zhaojing Zong , Fengmin Huo , Lingling Dong , Guangming Dai , Yunxu Li ,Hairong Huang ⁎, Naihui Chu ⁎.No in vitro synergistic effect of bedaquiline combined withfluoroquinolones, linezolid, and clofazimine against extensively drug-resistanttuberculosis. Diagn. Microbiol. Infect. Dis. . 2019,94(4):361-364.SCI

32. Zhijian Zhanga# , Jie Lub# , YingzhenDua# , Fei Xie#, Yufeng Wang, Baojun Suna *, Yu Pang,*.Comparison of in vitrosynergistic effect between clarithromycin or azithromycin in combination withamikacin against Mycobacterium intracellulare. J Glob Antimicrob Resist.2019,18:183-186.SCI

33. Shu’an Wen#, Wei Jing#, TingtingZhang#, Zhaojing Zong, Yi Xue, Yuanyuan Shang, Fen Wang,Hairong Huang*,NaihuiChu*, Yu Pang*.Comparison of in vitro activity of the nitroimidazoles delamanidand pretomanid against multidrug-resistant and extensively drug-resistanttuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. . 2019,38(7):1293-1296.SCI

34. Rongmei Liu#, Qian Liang#,YuanyuanShang#, Yifeng Ma, Fen Wang, Lingling Dong, Hairong Huang*, Mengqiu Gao*, YuPang*.GeneXpert of stool versus gastric lavage fluid for the diagnosis ofpulmonary tuberculosis in severely ill adults. Infection.2019,47(4):611-616.SCI

35. Liu Y #, Pang Y , Du J , Shu W , Ma Y ,Gao J , Zhang L , Xu S* , Li L *.An Overview of Tuberculosis-DesignatedHospitals in China, 2009-2015: A Longitudinal Analysis of National SurveyData.. Biomed Res Int.. 2019,Aug 20;2019:9310917.SCI

36. Xu J#, Li P , Zheng S , Shu W , Pang Y*..Prevalence and risk factors of pulmonary nontuberculous mycobacterialinfections in the Zhejiang Province of China.. Epidemiol Infect. . 2019,Sep11;147:e269.SCI

37. H Duan(#); X Chen(#); Z Li(#); YPang(#); W Jing(#); P Liu; T Wu; C Cai; J Shi; Z Qin; H Yin; C Qiu; C Li; YXia; W Chen; Z Ye; Z Li; G Chen; S Wang; Y Liu; L Chu; M Zhu; T Xu; Q Wang; JWang; Y Du; J Wang; N Chu(*); S Xu(*).Clofazimine improves clinical outcomes inmultidrug-resistant tuberculosis: a randomized controlled trial. ClinicalMicrobiology and Infection. 2019,25(2):190-195.SCI

38. Li X #, Deng Y , Wang J , Jing H , ShuW , Qin J , Pang Y *, Ma X *..Rapid Diagnosis Of Multidrug-ResistantTuberculosis Impacts Expenditures Prior To Appropriate Treatment: A PerformanceAnd Diagnostic Cost Analysis.. Infect Drug Resist. . 2019,Nov14;12:3549-3555.SCI

39. Yaoju Tan#, Biyi Su, Xingshan Cai, PingGuan, Xin Liu, Pinyun Ma, Huilin Zhou, Jianxiong Liu*, Yu Pang*.An automatedsmear microscopy system to diagnose tuberculosis in a high-burden setting..Clin Microbiol Infect. 2019,25(12):1553-1559.SCI

40. Yu Pang(#); Jun An(#); Wei Shu(#);Fengmin Huo; Naihui Chu; Mengqiu Gao;Shibing Qin; Hairong Huang; Xiaoyou Chen;Shaofa Xu(*).Epidemiology of Extrapulmonary Tuberculosis among Inpatients,China, 2008-2017. Emerg Infect Dis. 2019,25(3):457-464.SCI

41. Tang Peijun(#); Xu Ping(#); Shu Wei;Wang Xiafang; Guo Jian; Song Huafeng; Li Sumei; Pang Yu(*); Wu Meiying(*).Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonarytuberculosis patients with prior exposure to fluoroquinolones.. Infection andDrug Resistance. 2019,12:87-93.SCI

42. Jin Shi#,Jie Lu#,Shu'an Wen#,ZhaojingZong,Fengmin Huo,Jingjing Luo,Qian Liang,Yunxu Li,Hairong Huang*,Yu Pang*.InVitro Activity of PBTZ169 against Multiple Mycobacterium Species.. AntimicrobAgents Chemother. 2018,62(11):e01314-18.

43. Tan Y(#); Su B(#); Shu W; Cai X; KuangS; Kuang H; Liu J(*); Pang Y(*).Epidemiology of pulmonary disease due tonontuberculous mycobacteria in Southern China, 2013-2016. BMC PulmonaryMedicine. 2018,18:168.SCI

44. Kang Wanli(#); Wu Meiying; Yang Kunyun;Ertai A; Wu Shucai; Geng Shujun;Li Zhihui; Li Mingwu; Pang Yu(*); TangShenjie(*).Factors associated with negative T-SPOT.TB results amongsmear-negative tuberculosis patients in China.. Scientific Reports.2018,8(1):0-4236 .SCI

45. Ma Y(#); Pang Y(#); Shu W(#); Liu Y H;Ge Q P; Du J(*); Li L(*); Gao W W(*).Metformin reduces the relapse rate oftuberculosis patients with diabetes mellitus: experiences from 3-yearfollow-up. European Journal of Clinical Microbiology & Infectious Diseases.2018,37(7):1259-1263.SCI

46. Wu Xiaoguang(#); Pang Yu(#); SongYanhua(#); Dong Wenzhu; Zhang Tingting;Wen Shuan; Huang Hairong(*); GaoMengqiu(*). Implications of a school outbreak of multidrug-resistanttuberculosis in Northern China.. Epidemiology and Infection. 2018,146(5):584-588.SCI

47. Xu Caihong(#); Pang Yu(#); LiRenzhong(#); Ruan Yunzhou; Wang Lixia; Chen Mingting; Zhang Hui(*).Clinicaloutcome of multidrug-resistant tuberculosis patients receiving standardizedsecond-line treatment regimen in China.. Journal of Infection.2018,76(4):348-353.SCI

48. Zhang Z(#); Lu J(#); Song Y; PangY(*).In vitro activity between linezolid and other antimicrobial agents againstMycobacterium abscessus complex. Diagn Microbiol Infect Dis.2018,90(1):31-34.SCI

49. Xu P(#); Pang Y(#); Xu J; Chen H; TangP; Wu M(*),.Cytokine-induced killer cell therapy as a promising adjunctiveimmunotherapy for multidrug-resistant pulmonary TB: a case report.Immunotherapy. 2018,10(10):827-830.SCI

50. Huo Fengmin(#); Luo Jingjing(#); ShiJin; Zong Zhaojing; Jing Wei; Dong Wenzhu; Dong Lingling; Ma Yifeng; LiangQian; Shang Yuanyuan; Huang Hairong(*);Pang Yu(*).A 10-Year ComparativeAnalysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacteriumtuberculosis in China Is Associated with the Transmission of Strains HarboringCompensatory Mutations. Antimicrobial Agents and Chemotherapy.2018,62(4):e02303-17.SCI

51. Shi Jin(#); Dong Wenzhu; Ma Yifeng;Liang Qian; Shang Yuanyuan; Wang Fen; Huang Hairong(*); Pang Yu(*).GeneXpertMTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacteriumtuberculosis from Salivary Sputum.. Biomed Research International.2018,2018:1514381.SCI

52. Wang Qingfeng(#); Pang Yu(#); JingWei(#); Liu Yufeng; Wang Na; Yin Hongyun; Zhang Qing; Ye Zhizhong; Zhu Min; LiFujian; Liu Ping; Wu Tingting; Chen Wei; Wu Wei; Qin Zhihua; Qiu Chao; DengQunyi; Xu Tao; Wang Jing; Guo Ru;Du Yadong; Wang Jun; Huang Hairong(*); henXiaohong(*); Chu Naihui(*).Clofazimin e for Treatment of ExtensivelyDrug-Resistant Pulmonary Tuberculosis in China.. Antimicrobial Agents andChemotherapy. 2018,62(4) :e02149-17.SCI

53. Zong Zhaojing(#); Huo Fengmin(#); ShiJin(#); Jing Wei; Ma Yifeng; Liang Qian; Jiang Guanglu; Dai Guangming; HuangHairong(*); Pang Yu(*).Relapse Versus Reinfection of Recurrent TuberculosisPatients in a National Tuberculosis Specialized Hospital in Beijing, China.Frontiers in Microbiology. 2018,9:0-1858.SCI

54. Zong Zhaojing(#); Jing Wei(#); ShiJin(#); Wen Shu'an; Zhang Tingting; Huo Fengmin; Shang Yuanyuan; Liang Qian;Huang Hairong(*); Pang Yu(*).Comparison of In Vitro Activity and MICDistributions between the Novel Oxazolidinone Delpazolid and Linezolid againstMultidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosisin China. Antimicrobial Agents and Chemotherapy. 2018,62(8):e00165-18.SCI

55. An Jun(#); Bai Xuejuan(#); Gao Mengqiu;Chu Naihui; Huang Hairong; Xu Hongyin; Zhang Xiuping; Li Baoxia; Huang Cailiu;Cai Haixia; Zhang Fengqin; Pang Yu(*); Li Liang(*).Antituberculosis drugprescribing for inpatients in a national tuberculosis hospital in China,2011-2015.. J Glob Antimicrob Resist. 2018,14:17-22.SCI

56. Pang Y(#); Zhu D(#); Zheng H; Shen J;Hu Y; Liu J(*); Zhao Y(*).Prevalence and molecular characterization ofpyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosisisolates from Southern China.. BMC Infect Dis. 2017,17(1):711.SCI

57. Liu Z(#); Pan A(#); Wu B; Zhou L; He H;Meng Q; Chen S; Pang Y(*); Wang X(*).Feasibility of a new model for earlydetection of patients with multidrug-resistant tuberculosis in a developedsetting of eastern China. Trop Med Int Health. 2017,22(10):1328-1333.SCI

58. Pang Y(#)(*); Zong Z(#); Huo F; Jing W;Ma Y; Dong L; Li Y; Zhao L; Fu Y;Huang H(*).In Vitro Drug Susceptibility ofBedaquiline, Delamanid, Linezolid, Clofazimine, Moxifloxacin, and Gatifloxacinagainst Extensively Drug-Resistant Tuberculosis in Beijing, China. AntimicrobAgents Chemother. 2017,61(10):e00900-17.SCI

59. Pang Y(#); Shang Y(#); Lu J; Liang Q;Dong L; Li Y; Zhao L; Jiang G;Huang H(*).GeneXpert MTB/RIF assay in thediagnosis of urinary tuberculosis from urine specimens. Sci Rep.2017,7(1):6181.SCI

60. Tan Y(#); Li Q(#); Wang Q(#); Sun H(#);Chen J; Cai X; Yao Y; Bao X; Wang C; Liu Y; Wu X; Pang Y(*); ZhaoY(*).Evaluation of the MTBDRplus 2.0 assay for the detection of multidrugresistance among persons with presumptive pulmonary TB in China. Sci Rep.2017,7(1):3364.SCI

61. Ma Y(#); Pang Y(#); Du J(#); Liu Y; LiL(*); Gao W(*).Clinical outcomes for multi- and extensively drug resistanttuberculosis patients with adjunctive resectional lung surgery in Beijing,China. J Thorac Dis. 2017,9(3):841-845.SCI

62. Zhang, Zhijian(#); Lu, Jie(#); Liu,Min(#); Wang, Yufeng; Zhao, Yanlin(*);Pang, Yu(*).In vitro activity ofclarithromycin in combination with other antimicrobial agents againstMycobacterium abscessus and Mycobacterium massiliense.. International Journalof Antimicrobial Agents,. 2017,49(3):383-386.SCI

63. Pang, Yu(#); Zhang, Zhijian(#); Wang,Yufeng; Wang, Shengfen; Song, Yuanyuan; Zhao, Bing; Zhou, Yang; Ou, Xichao; Li,Qiang; Xia, Hui; Zheng, Yang;Fang, Xiangqun(*); Zhao, Yanlin(*).Genotyping andPrevalence of Pyrazinamide-and Moxifloxacin-Resistant Tuberculosis in China,2000 to 2010.. Antimicrobial Agents and Chemotherapy. 2017,61(2):e02170-16.SCI

64. Wang, Li(#); Zhang, Zhiguo(#); Yan,Qiuli(#); Lu, Jie; Gao, Baoyin; Zhao, Yanlin; Pang, Yu(*).Diagnostic dilemma ofpulmonary tuberculosis among adults with severe mental illness in Beijing,hina.. BMC Infectious Diseases. 2017,17(1):83.SCI

65. Chen L(#); Pang Y(#); Ma L; Yang H; RuH; Yang X; Yan S; Jia M; Xu L(*).First Insight into the Molecular Epidemiologyof Mycobacterium tuberculosis Isolates from the Minority Enclaves ofSouthwestern China. Biomed Res Int. 2017,2017:2505172.SCI

66. Han Xi Qin(#); Pang Yu(#); Ma Yan(#);Liu Yu Hong; Guo Ru; Shu Wei; Huang Xue Rui; Ge Qi Ping; Du Jian(*); Gao WeiWei(*) .Prevalence and Risk Factors Associated with Adverse Drug Reactionsamong Previously Treated Tuberculosis Patients in China. 生物医学与环境科学(英文版). 2017,30(2):139-142.SCI

67. Pang Y(#)(*); Zheng H(#); Tan Y; SongY; Zhao Y(*).In vitro activity of bedaquiline against nontuberculousmycobacteria in China. Antimicrob Agents Chemother. 2017,61(5):e02627-16.SCI

68. Pang, Yu(#); Tan, Yaoju(#); Chen,Jin(#); Li, Yanming(#); Zheng, Huiwen;Song, Yuanyuan; Zhao, Yanlin(*).Diversityof nontuberculous mycobacteria in eastern and southern China: a cross-sectionalstudy. European Respiratory Journal. 2017,49(3):1601429.SCI

69. Pang Y(#); Lu J(#); Huo F; Ma Y; ZhaoL; Li Y; Liang Q; Chu N(*); Gao M(*);Huang H(*).Prevalence and treatmentoutcome of extensively drug-resistant tuberculosis plus additional drugresistance from the National Clinical Center for Tuberculosis in China: Afive-year review. J Infect. 2017,75(5):433-440.SCI

70. Jing W(#); Pang Y(#); Zong Z; Wang J;Guo R; Huo F; Jiang G; Ma Y; Huang H(*); Chu N(*).Rifabutin ResistanceAssociated with Double Mutations in rpoB Gene in Mycobacterium tuberculosisIsolates. Front Microbiol. 2017,14(8):1768.SCI

71. Tan Y(#); Su B; Zheng H; Song Y; WangY; Pang Y(*).Molecular Characterization of Prothionamide-ResistantMycobacterium tuberculosis Isolates in Southern China. Front Microbiol.2017,8(1):2358.SCI

72. Xie ZY(#); Huang GF; Gao H; Chi YQ;Wang YX; Pang Y(*); Wang JP(*).Nosocomial Infection Surveillance in aTuberculosis Specialized Hospital in China. Biomed Environ Sci.2017,30(9):691-694.SCI

73. Pang Y(#)(*); Lu J(#); Su B; Zheng H;Zhao Y(*).Misdiagnosis of tuberculosis associated with some species ofnontuberculous mycobacteria by GeneXpert MTB/RIF assay. Infection.2017,45(5):677-681.SCI

74. Du, Jian(#); Pang, Yu(#); Ma, Yan(#);Mi, Fengling; Liu, Yuhong; Li,Liang(*).Prevalence of tuberculosis among healthcare workers in tuberculosis specialized hospitals in China.. Journal ofOccupational Health. 2017,59(3)::292-295.SCI

75. Tan Y(#); Su B; Zheng H; Wang Y; PangY(*).Prothionamide susceptibility testing of Mycobacterium tuberculosis usingthe resazurin microtitre assay and the BACTECMGIT 960 system. Eur J ClinMicrobiol Infect Dis. 2017,36(5):779-782.SCI

76. Pang Y(#); Du J(#); Qin ZZ(#);Greenwald Z; Liu Y; Mi F; Zhao Y; Li L(*).An overview on tuberculosis-specifichospitals in China in 2009: Results of a national survey. Eur Respir J.2016,47(5):1584-1587.SCI

77. Li, Yanming(#); Pang, Yu(#); Tong,Xunliang; Zheng, Huiwen; Zhao, Yanlin(*); Wang, Chen(*).Mycobacterium kansasiiSubtype I Is Associated With Clarithromycin Resistance in China.. Frontiers inMicrobiology. 2016,7:2097-2097.SCI

78. Wang, Ting(#); Feng, Guo-Dong(#); Pang,Yu(#); Yang, Yi-Ning; Dai, Wen; Zhang, Lin; Zhou, Lin-Fu; Yang, Jia-Lei; Zhan,Li-Ping; Marais, Ben J; Zhao,Yan-Lin(*); Zhao, Gang(*).Sub-optimal Specificityof Modified Ziehl-Neelsen Staining for Quick Identification of Tuberculous Meningitis..Frontiers in Microbiology. 2016,7:2096.SCI

79. Pang, Yu(#); Su, Biyi(#); Zheng,Huiwen; Zhang, Zhiguo; Ma, Aijing;Wang, Yufeng; Zhao, Yanlin(*).FactorsAssociated with Missed Detection of Mycobacterium tuberculosis by AutomatedBACTEC MGIT 960 System.. Biomed Research International. 2016,2016:5972021.SCI

80. Zhang, Dan(#); Wang, Yufeng; Lu, Jie;Pang, Yu(*).In Vitro Activity of beta-Lactams in Combination withbeta-Lactamase Inhibitors against Multidrug-Resistant Mycobacteriumtuberculosis Isolates. Antimicrobial Agents and Chemotherapy.2016,60(1):393-399.SCI

81. Liu, Zhengwei(#); Pang, Yu(#); Chen,Songhua; Wu, Beibei; He, Haibo;Pan, Aizhen; Wang, Xiaomeng(*).A First Insightinto the Genetic Diversity and Drug Susceptibility Pattern of Mycobacteriumtuberculosis Complex in Zhejiang, China.. Biomed Research International.2016,2016:8937539.SCI

82. Liqun Zhang(#); Yu Pang(#); Xia Yu(#);Yufeng Wang; Jie Lu; Mengqiu Gao(*); Hairong Huang(*); Yanlin Zhao(*),.Riskfactors for pulmonary cavitation in tuberculosis patients from China. EmergMicrobes Infect. 2016,5(10):e110.SCI

83. An, Jun(#); Gao, Mengqiu; Chu, Naihui;Huang, Hairong; Pang, Yu(*); Li,Liang(*).Transregional movement ofmultidrug-resistant tuberculosis in north China: an underlying threat totuberculosis control.. Scientific Reports. 2016,6:29727.SCI

84. Pang, Yu(#); Dong, Haiyan(#); Tan,Yaoju(#); Deng, Yunfeng(#); Cai, Xingshan; Jing, Hui; Xia, Hui; Li, Qiang; Ou,Xichao; Su, Biyi; Li, Xuezheng;Zhang, Zhiying; Li, Junchen; Zhang, Jiankang;Huan, Shitong; Zhao, Yanlin(*).Rapid diagnosis of MDR and XDR tuberculosis withthe MeltPro TB assay in China.. Scientific Reports. 2016,6:25330.SCI

85. Pang, Yu(#); Zhao, Aihua(#); Cohen,Chad; Kang, Wanli; Lu, Jie; Wang,Guozhi; Zhao, Yanlin; Zheng, Suhua(*).Currentstatus of new tuberculosis vaccine in children.. Hum Vaccin Immunother.2016,12(4):960-970.SCI

86. Wang T(*); Feng GD(#); Pang Y(#); LiuJY; Zhou Y; Yang YN; Dai W; Zhang L; Li Q; Gao Y; Chen P; Zhan LP; Marais BJ;Zhao YL(*); Zhao G(*).High rate of drug resistance among tuberculous meningitiscases in Shaanxi province, China,. Sci Rep. 2016,6:25251.SCI

87. Yu Pang(#)(*); Zhongdong Wang(#);Huiwen Zheng; Yuanyuan Song; Yufeng Wang; Yanlin Zhao(*).Pyrazinamideresistance determined by liquid culture at low pH better correlates withgenetic mutations in MDR tuberculosis isolates. Journal of MicrobiologicalMethods. 2015,119(12):142-144.SCI

88. Du, Jian(#); Emilio, Dirlikov(#); Pang,Yu(#); Ma, Yan; Mi, Fengling;Liu, Yuhong; Li, Liang(*).TuberculosisHospitalization Fees and Bed Utilization in China from 1999 to 2009: TheResults of a National Survey of Tuberculosis Specialized Hospitals.. PLos One.2015,10(10):e0139901.SCI

89. Pang, Yu(#); Zhou, Yang(#); Wang,Shengfen; Song, Yuanyuan; Ou, Xichao;Zhao, Bing; Zhang, Zhijian; Zhao,Yanlin(*),.Prevalence and risk factors of mixed Mycobacterium tuberculosiscomplex infections in China.. Journal of Infection. 2015,71(2):231-237.SCI

90. Zhang, Zhijian(#); Pang, Yu(#)(*);Wang, Yufeng; Cohen, Chad; Zhao,Yanlin(*); Liu, Changting(*).Differences inrisk factors and drug susceptibility between Mycobacterium avium andMycobacterium intracellulare lung diseases in China.. International Journal ofAntimicrobial Agents. 2015,45(5):491-495.SCI

91. Yang, Xiujun(#); Yuan, Yanli(#); Pang,Yu(#); Wang, Bo; Bai, Yunlong;Wang, Yanhua; Yu, Baozhu; Zhang, Zhiying; Fan,Ming(*); Zhao, Yanlin(*).The burden of MDR/XDR tuberculosis in coastal plainspopulation of China.. PLos One. 2015,10(2):e0117361.SCI

92. Zou, Lin(#); Liu, Min; Wang, Yufeng;Lu, Jie; Pang, Yu(*).Determination of in vitro synergy between linezolid andother antimicrobial agents against Mycobacterium tuberculosis isolates..Tuberculosis (Edinb). 2015,95(6):839-842.SCI

93. Pang, Yu(#); Lu, Jie(#); Yang, Jian; Wang,Yufeng; Cohen, Chad; Ni, Xin(*); Zhao, Yanlin(*).A novel method for diagnosisof smear-negative tuberculosis patients by combining a random unbiased Phi29amplification with a specific real-time PCR. Tuberculosis (Edinb).2015,95(4):411-414.SCI

94. Pang, Yu(#); Kang, Wanli(#); Zhao,Aihua(#); Liu, Guan; Du, Weixin; Xu,Miao; Wang, Guozhi(*); Zhao, Yanlin(*);Zheng, Suhua(*).The effect of bacille Calmette-Guerin vaccination at birth onimmune response in China.. Vaccine. 2015,33(1):209-213.SCI

95. Zhang, Zhijian(#); Li, Tianzhi(#); Qu,Geping; Pang, Yu(*); Zhao, Yanlin(*).In vitro synergistic activity ofclofazimine and other antituberculous drugs against multidrug-resistantMycobacterium tuberculosis isolates.. Internation al Journal of AntimicrobialAgents. 2015,45(1):71-75.SCI

96. Zhijian Zhang(#); Jie Lu(#); YufengWang; Yu Pang(*); Yanlin Zhao(*).Automated liquid culture system missesisoniazid heteroresistance in Mycobacteriumtuberculosis isolates with mutationsin the promoter region of the inhA gene. Eur J Clin Microbiol Infect Dis.2015,34(3):555-560.SCI

97. Zhang, Zhijian(#); Lu, Jie(#); Liu,Min(#); Wang, Yufeng; Qu, Geping; Li,Hongxia; Wang, Jichun; Pang, Yu(*); Liu,Changting(*); Zhao, Yanlin(*).Genotyping and molecular characteristics ofmultidrug-resistant Mycobacterium tuberculosis. Journal of Infection.2015,70(4):335-345.SCI

98. Zhijian Zhang#,Jie Lu#,Min Liu#,YufengWang,Geping Qu,Hongxia Li,Jichun Wang,Yu Pang*,Changting Liu*,YanlinZhao*.Genotyping and molecular characteristics of multidrug-resistantMycobacterium tuberculosis isolates from China. J Infect.2015,70(4):335-345.SCI

99. Yu Pang#,Jian Du#,Zhi Ying Zhang,XiChao Ou,Qiang Li,Hui Xia,Yan Qu*,Yan Lin Zhao*.The feasibility of sputumtransportation system in China: effect of sputum storage on the mycobacterialdetection. Biomed Environ Sci. 2015,27(12):982-986.SCI

三、主编或副主编的著作/译著

1. 《结核病实验室检验规程》,主编,人民卫生出版社,201506